Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review

Abstract Background and aims Refugees are at higher risk for hepatitis B (HBV) and hepatitis C (HCV), but often face unique healthcare barriers to vaccination, testing, and treatment. This scoping review aimed to identify and characterize HBV and HCV prevention and care services serving refugee popu...

Full description

Bibliographic Details
Main Authors: Ankeeta Saseetharran, Lindsey Hiebert, Neil Gupta, Françoise Nyirahabihirwe, Innocent Kamali, John W. Ward
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-023-08861-1
_version_ 1797199641450643456
author Ankeeta Saseetharran
Lindsey Hiebert
Neil Gupta
Françoise Nyirahabihirwe
Innocent Kamali
John W. Ward
author_facet Ankeeta Saseetharran
Lindsey Hiebert
Neil Gupta
Françoise Nyirahabihirwe
Innocent Kamali
John W. Ward
author_sort Ankeeta Saseetharran
collection DOAJ
description Abstract Background and aims Refugees are at higher risk for hepatitis B (HBV) and hepatitis C (HCV), but often face unique healthcare barriers to vaccination, testing, and treatment. This scoping review aimed to identify and characterize HBV and HCV prevention and care services serving refugee populations globally. Methods A literature search was conducted on Embase, Cochrane, and PubMed databases. Research studies published in English between January 2010 to July 2022 describing an HBV or HCV prevention, testing, or treatment intervention for refugees were included. Results There were a total of 69 articles reporting viral hepatitis prevalence, implementation of services, or economic modelling. Of the 38 implementation studies, 14 were stand-alone HBV and/or HCV interventions, while 24 studies included HBV and/or HCV in an intervention targeting multiple infectious diseases and/or parasitic infections. Interventions commonly included a testing (n = 30) or referral (n = 24) component. Frequently reported features to promote program accessibility included bilingual services (n = 25), community partnerships (n = 21), and multidisciplinary staff members (n = 18), such as cultural and/or linguistic mediators, community health workers, community health leaders, lay health workers, local health staff, members of the refugee community, and social workers. The most commonly reported challenge was the transience of refugees (n = 5). Twenty studies noted funding sources, of which twelve reported governmental funding (not including national health insurance) and eight reported that refugees received national health insurance. Conclusions This is the first scoping review to characterize the types of hepatitis prevention, screening, and treatment interventions serving refugee populations globally. Published experiences of HBV and HCV services for refugee populations remain limited. Additional efforts are needed to disseminate models of hepatitis interventions for refugees to ensure access to care for this key population. To achieve hepatitis elimination globally, best practices must be identified and shared to expand access to hepatitis services for refugee populations.
first_indexed 2024-03-09T01:21:57Z
format Article
id doaj.art-e4db62ee0dc9446d99ce1cd369b2500d
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-04-24T07:18:59Z
publishDate 2023-12-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-e4db62ee0dc9446d99ce1cd369b2500d2024-04-21T11:10:15ZengBMCBMC Infectious Diseases1471-23342023-12-0123111210.1186/s12879-023-08861-1Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping reviewAnkeeta Saseetharran0Lindsey Hiebert1Neil Gupta2Françoise Nyirahabihirwe3Innocent Kamali4John W. Ward5Coalition for Global Hepatitis EliminationCoalition for Global Hepatitis EliminationCoalition for Global Hepatitis EliminationPartners in Health/Inshuti Mu BuzimaPartners in Health/Inshuti Mu BuzimaCoalition for Global Hepatitis EliminationAbstract Background and aims Refugees are at higher risk for hepatitis B (HBV) and hepatitis C (HCV), but often face unique healthcare barriers to vaccination, testing, and treatment. This scoping review aimed to identify and characterize HBV and HCV prevention and care services serving refugee populations globally. Methods A literature search was conducted on Embase, Cochrane, and PubMed databases. Research studies published in English between January 2010 to July 2022 describing an HBV or HCV prevention, testing, or treatment intervention for refugees were included. Results There were a total of 69 articles reporting viral hepatitis prevalence, implementation of services, or economic modelling. Of the 38 implementation studies, 14 were stand-alone HBV and/or HCV interventions, while 24 studies included HBV and/or HCV in an intervention targeting multiple infectious diseases and/or parasitic infections. Interventions commonly included a testing (n = 30) or referral (n = 24) component. Frequently reported features to promote program accessibility included bilingual services (n = 25), community partnerships (n = 21), and multidisciplinary staff members (n = 18), such as cultural and/or linguistic mediators, community health workers, community health leaders, lay health workers, local health staff, members of the refugee community, and social workers. The most commonly reported challenge was the transience of refugees (n = 5). Twenty studies noted funding sources, of which twelve reported governmental funding (not including national health insurance) and eight reported that refugees received national health insurance. Conclusions This is the first scoping review to characterize the types of hepatitis prevention, screening, and treatment interventions serving refugee populations globally. Published experiences of HBV and HCV services for refugee populations remain limited. Additional efforts are needed to disseminate models of hepatitis interventions for refugees to ensure access to care for this key population. To achieve hepatitis elimination globally, best practices must be identified and shared to expand access to hepatitis services for refugee populations.https://doi.org/10.1186/s12879-023-08861-1Hepatitis BHepatitis CRefugeeTestingTreatmentVaccination
spellingShingle Ankeeta Saseetharran
Lindsey Hiebert
Neil Gupta
Françoise Nyirahabihirwe
Innocent Kamali
John W. Ward
Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review
BMC Infectious Diseases
Hepatitis B
Hepatitis C
Refugee
Testing
Treatment
Vaccination
title Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review
title_full Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review
title_fullStr Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review
title_full_unstemmed Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review
title_short Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review
title_sort prevention testing and treatment interventions for hepatitis b and c in refugee populations results of a scoping review
topic Hepatitis B
Hepatitis C
Refugee
Testing
Treatment
Vaccination
url https://doi.org/10.1186/s12879-023-08861-1
work_keys_str_mv AT ankeetasaseetharran preventiontestingandtreatmentinterventionsforhepatitisbandcinrefugeepopulationsresultsofascopingreview
AT lindseyhiebert preventiontestingandtreatmentinterventionsforhepatitisbandcinrefugeepopulationsresultsofascopingreview
AT neilgupta preventiontestingandtreatmentinterventionsforhepatitisbandcinrefugeepopulationsresultsofascopingreview
AT francoisenyirahabihirwe preventiontestingandtreatmentinterventionsforhepatitisbandcinrefugeepopulationsresultsofascopingreview
AT innocentkamali preventiontestingandtreatmentinterventionsforhepatitisbandcinrefugeepopulationsresultsofascopingreview
AT johnwward preventiontestingandtreatmentinterventionsforhepatitisbandcinrefugeepopulationsresultsofascopingreview